Minaris Advanced Therapies
The Director, Sales and Business Development (covering North America) drives revenue growth and expands market share for Minaris Advanced Therapies in the cell and gene therapy landscape. This role leads sales and business development strategies, builds relationships with key departments, and identifies new opportunities to close deals. The position is instrumental in positioning the company as a partner of choice in the CGT market.
Headquarters
Philadelphia, Pennsylvania, United States
Company Size
501-1000 employees
Founded
2025
Minaris Advanced Therapies is a contract development and manufacturing organization (CDMO) focused on end-to-end manufacturing and advanced testing for cell and gene therapies. They provide GMP manufacturing, analytical and quality testing services across development through commercial supply, supported by a global network of facilities. With 7,500+ GMP batches and roughly 40 years of testing experience, Minaris positions itself as an experienced partner for biotech and pharma companies advancing cell and gene therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Minaris Advanced Therapies.
Minaris Advanced Therapies didn’t post a salary, so this is our estimate from similar listings.
Director Business Development
OmniaBio
Business Development Account Director, Cell Gene Therapy
Catalent
Ceel & Gene Therapy Technical Development
Global Channel Management
Director, Business Development - Eastern U.S.
Landmark Bio
Senior Account Director, Cell & Gene Therapy
Catalent
Cell and Gene Therapy (CGT) Quality Program Owner m/f/d
JobAps